Allulose is a dietary sweetener with GRAS status as a food ingredient, not a pharmaceutical compound, and it does not directly bind to or activate GLP-1 receptors as prescription GLP-1 agonist medications do
Energy Expenditure Research: investigators use the compound to separate the contribution of increased energy expenditure from that of reduced energy intake in rodent models
The correct dosage of L-Carnitine can make a major difference in how effectively your body performs
There are virtually no data to inform best practice in the care of people with diabetes and advanced CKD, particularly in dialysis-dependent kidney disease
Building on the promising Phase I clinical data generated by Eccogene, we believe this oral GLP-1RA molecule could offer alternatives to current injectable therapies both as a potential monotherapy as well as in combination for cardiometabolic diseases such as type-2 diabetes, as well as for obesity, Sharon Barr, EVP of biopharmaceuticals research and development at AstraZeneca, said in a statement